Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 690 participants.

Also called NCT01962545

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 690 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01962545
Other papers using this trial's data
  • Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation Circulation, 2019-01-29 DOI, PubMed 30586700

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01962545. Randomized; no masking; primary purpose treatment. Start 2013-11-05 (actual); primary completion 2017-05-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study
Acronym
OAC-ALONE
Intervention (Drug)
OAC alone
Lead sponsor
Satoshi Shizuta (class: other)
Collaborator
Research Institute for Production Development (class: not stated)
Collaborator
Daiichi Sankyo Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct01962545
Content hash
d3e3d76e93eeedff9fc5ba37a9bed089be67e5e2a9391d9b61ac2a7dccf264a4